JEREMIAH MARTINEZ: Open Payments
NPI 1255458386 · PANORAMA CITY, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$735 in 23 payments from 6 companies in 2025. Trend: 2023 $451 · 2024 $316 · 2025 $735
Food & beverage: $735
| Company | Payments | Amount |
|---|---|---|
| Neurocrine BioSciences, Inc. | 11 | $302 |
| Janssen Pharmaceuticals, Inc | 6 | $189 |
| Teva Pharmaceuticals USA, Inc. | 2 | $151 |
| Lundbeck LLC | 2 | $37 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $29 |
| Alkermes, Inc. | 1 | $27 |
Products named: INGREZZA, INVEGA SUSTENNA, UZEDY, ABILIFY ASIMTUFII, CAPLYTA, VIVITROL.
Industry payments across CA — which companies pay providers there.
